• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 25-NSE filed by Chavant Capital Acquisition Corp.

    12/22/23 12:17:36 PM ET
    $CLAY
    Blank Checks
    Finance
    Get the next $CLAY alert in real time by email
    NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
    UNITED STATES
    OMB APPROVAL
    OMB Number: 3235-0080
    Expires: March 31, 2018
    Estimated average burden
    hours per response: 1.7
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM 25
    NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
    UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
    Commission File Number 333-257459
    Issuer: Chavant Capital Acquisition Corp.
    Exchange: Nasdaq Stock Market LLC
    (Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)
    Address: 445 Park Avenue
    9th Floor
    New York NEW YORK 10022
    Telephone number: 7,817,999,049
    (Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)
    Unit
    (Description of class of securities)
    Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:
    17 CFR 240.12d2-2(a)(1)
    17 CFR 240.12d2-2(a)(2)
    17 CFR 240.12d2-2(a)(3)
    17 CFR 240.12d2-2(a)(4)
    Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. 1
    Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.
    Pursuant to the requirements fo the Securities Exchange Act of 1934, Nasdaq Stock Market LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.
    2023-12-22 By Tara Petta AVP
    Date Name Title
    1 Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $CLAY alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CLAY

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CLAY
    Leadership Updates

    Live Leadership Updates

    See more
    • LinKinVax Appoints Dr. Jiong Ma as Independent Board Member

      An international expert in the financing and growth of high tech businesses LinKinVax, a clinical-stage biotechnology company specializing in the treatment of infectious diseases and certain forms of cancer, announces the appointment of Dr. Jiong Ma as independent board member. "As we enter the clinical stages of a number of drug candidates (HPV, Covid) resulting from our innovative vaccine platform, I am delighted to welcome Dr. Jiong Ma as an addition to our board. With a longstanding focus on the financing and growth of high tech businesses, her role will be to support us in our platform development strategy and to help us achieve our ambitions on a global scale. Dr. Jiong Ma benefits

      5/4/22 6:00:00 AM ET
      $AVXL
      $CLAY
      $SES
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
      Blank Checks
      Finance

    $CLAY
    SEC Filings

    See more
    • SEC Form NT 10-Q filed by Chavant Capital Acquisition Corp.

      NT 10-Q - MOBIX LABS, INC (0001855467) (Filer)

      2/15/24 4:52:22 PM ET
      $CLAY
      Blank Checks
      Finance
    • SEC Form 424B3 filed by Chavant Capital Acquisition Corp.

      424B3 - MOBIX LABS, INC (0001855467) (Filer)

      1/23/24 8:55:31 PM ET
      $CLAY
      Blank Checks
      Finance
    • Chavant Capital Acquisition Corp. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Leadership Update, Financial Statements and Exhibits

      8-K - MOBIX LABS, INC (0001855467) (Filer)

      1/23/24 5:25:19 PM ET
      $CLAY
      Blank Checks
      Finance

    $CLAY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Goerner Frederick C was granted 317,244 shares (SEC Form 4)

      4 - Chavant Capital Acquisition Corp. (0001855467) (Issuer)

      12/26/23 9:51:34 PM ET
      $CLAY
      Blank Checks
      Finance
    • Peterson James J was granted 2,404,845 shares (SEC Form 4)

      4 - Chavant Capital Acquisition Corp. (0001855467) (Issuer)

      12/26/23 9:50:44 PM ET
      $CLAY
      Blank Checks
      Finance
    • Carpou Bill was granted 73,752 shares (SEC Form 4)

      4 - Chavant Capital Acquisition Corp. (0001855467) (Issuer)

      12/26/23 9:48:00 PM ET
      $CLAY
      Blank Checks
      Finance

    $CLAY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Chavant Capital Acquisition Corp. (Amendment)

      SC 13G/A - MOBIX LABS, INC (0001855467) (Subject)

      2/9/24 7:26:55 AM ET
      $CLAY
      Blank Checks
      Finance
    • SEC Form SC 13D filed by Chavant Capital Acquisition Corp.

      SC 13D - Chavant Capital Acquisition Corp. (0001855467) (Subject)

      1/2/24 5:21:14 PM ET
      $CLAY
      Blank Checks
      Finance
    • SEC Form SC 13G filed by Chavant Capital Acquisition Corp.

      SC 13G - Chavant Capital Acquisition Corp. (0001855467) (Subject)

      1/2/24 5:18:58 PM ET
      $CLAY
      Blank Checks
      Finance

    $CLAY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chavant Capital Partners Llc disposed of 658,631 shares, bought $1,997,370 worth of shares (199,737 units at $10.00) and acquired 272,182 shares, decreasing direct ownership by 12% to 1,394,101 units (SEC Form 4)

      4 - Chavant Capital Acquisition Corp. (0001855467) (Issuer)

      12/26/23 6:01:22 PM ET
      $CLAY
      Blank Checks
      Finance

    $CLAY
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Mobix Labs, Inc. Closes Business Combination with Chavant Capital Acquisition Corp., Becomes Publicly Traded

      IRVINE, Calif., Dec. 21, 2023 (GLOBE NEWSWIRE) -- Mobix Labs, Inc. ("Mobix Labs" or the "Company"), a fabless semiconductor company developing disruptive next-generation connectivity technologies for 5G infrastructure, satellite communications and defense industries, today announced that its previously announced business combination with Chavant Capital Acquisition Corp. ("Chavant") (NASDAQ:CLAY) has closed, resulting in Mobix Labs becoming a publicly traded company. The business combination and all other proposals presented were approved at an extraordinary general meeting of Chavant shareholders held on December 18, 2023. In connection with the completion of the business combination,

      12/21/23 8:59:37 PM ET
      $CLAY
      Blank Checks
      Finance
    • Mobix Labs, Inc. and Chavant Capital Acquisition Corp. Announce Effectiveness of Registration Statement on Form S-4

      IRVINE, Calif., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Mobix Labs, Inc. ("Mobix Labs" or the "Company"), a fabless semiconductor company developing disruptive next-generation connectivity technologies for 5G infrastructure, satellite communications and defense industries, and Chavant Capital Acquisition Corp. (NASDAQ:CLAY) ("Chavant"), a publicly traded special purpose acquisition company, today announced that the U.S. Securities and Exchange Commission (the "SEC") has declared effective the Registration Statement on Form S-4 (as amended, the "Registration Statement") filed by Chavant and relating to the previously announced proposed business combination between Mobix Labs and Chavant (the "Bus

      11/21/23 4:07:00 PM ET
      $CLAY
      Blank Checks
      Finance
    • Mobix Labs, Inc. and Chavant Capital Acquisition Corp. Announce Filing of Registration Statement on Form S-4 in Connection With Proposed Business Combination

      IRVINE, Calif., April 10, 2023 (GLOBE NEWSWIRE) -- Mobix Labs, Inc. ("Mobix Labs" or the "Company"), an innovative provider of next generation wireless mmWave 5G and connectivity solutions, and Chavant Capital Acquisition Corp. (NASDAQ:CLAY) ("Chavant"), a publicly-traded special purpose acquisition company, announced today the filing by Chavant with the U.S. Securities and Exchange Commission ("SEC") of a registration statement on Form S-4 (the "Registration Statement") on April 7, 2023, relating to the previously announced proposed business combination of Chavant and Mobix Labs. The Registration Statement contains a preliminary proxy statement/prospectus in connection with the previousl

      4/10/23 8:00:00 AM ET
      $CLAY
      Blank Checks
      Finance